|
Ultralife Corporation (ULBI) Évaluation DCF
US | Industrials | Electrical Equipment & Parts | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Ultralife Corporation (ULBI) Bundle
Découvrez le véritable potentiel d'Ultralife Corporation (ULBI) avec notre calculatrice avancée DCF! Ajustez les hypothèses clés, explorez divers scénarios et évaluez comment les changements affectent la valorisation UltraLife Corporation (ULBI) - le tout dans un modèle Excel pratique.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106.8 | 107.7 | 98.3 | 131.8 | 158.6 | 177.1 | 197.7 | 220.8 | 246.5 | 275.2 |
| Revenue Growth, % | 0 | 0.85865 | -8.77 | 34.17 | 20.33 | 11.65 | 11.65 | 11.65 | 11.65 | 11.65 |
| EBITDA | 10.4 | 8.6 | 4.0 | 4.6 | 15.0 | 12.3 | 13.8 | 15.4 | 17.2 | 19.2 |
| EBITDA, % | 9.72 | 8.02 | 4.12 | 3.48 | 9.48 | 6.96 | 6.96 | 6.96 | 6.96 | 6.96 |
| Depreciation | 2.7 | 2.9 | 3.5 | 4.5 | 3.9 | 5.2 | 5.8 | 6.5 | 7.3 | 8.1 |
| Depreciation, % | 2.57 | 2.72 | 3.6 | 3.38 | 2.47 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
| EBIT | 7.6 | 5.7 | .5 | .1 | 11.1 | 7.1 | 7.9 | 8.9 | 9.9 | 11.0 |
| EBIT, % | 7.15 | 5.29 | 0.51899 | 0.09784587 | 7.02 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 |
| Total Cash | 7.4 | 10.7 | 8.4 | 5.7 | 10.3 | 12.8 | 14.3 | 16.0 | 17.8 | 19.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 30.1 | 21.1 | 20.2 | 27.8 | 31.8 | 38.8 | 43.3 | 48.3 | 53.9 | 60.2 |
| Account Receivables, % | 28.19 | 19.55 | 20.59 | 21.07 | 20.02 | 21.88 | 21.88 | 21.88 | 21.88 | 21.88 |
| Inventories | 29.8 | 28.2 | 33.2 | 41.2 | 42.2 | 51.6 | 57.6 | 64.3 | 71.8 | 80.2 |
| Inventories, % | 27.87 | 26.17 | 33.77 | 31.24 | 26.61 | 29.13 | 29.13 | 29.13 | 29.13 | 29.13 |
| Accounts Payable | 9.4 | 10.8 | 9.8 | 16.1 | 11.3 | 17.1 | 19.1 | 21.3 | 23.8 | 26.5 |
| Accounts Payable, % | 8.79 | 10.06 | 10 | 12.19 | 7.15 | 9.64 | 9.64 | 9.64 | 9.64 | 9.64 |
| Capital Expenditure | -6.3 | -3.1 | -2.8 | -1.7 | -2.6 | -5.1 | -5.7 | -6.4 | -7.2 | -8.0 |
| Capital Expenditure, % | -5.88 | -2.88 | -2.86 | -1.27 | -1.61 | -2.9 | -2.9 | -2.9 | -2.9 | -2.9 |
| Tax Rate, % | 21.06 | 21.06 | 21.06 | 21.06 | 21.06 | 21.06 | 21.06 | 21.06 | 21.06 | 21.06 |
| EBITAT | 5.9 | 4.2 | .8 | .0 | 8.8 | 5.1 | 5.7 | 6.3 | 7.1 | 7.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -48.1 | 16.2 | -3.7 | -6.5 | .4 | -5.5 | -2.8 | -3.1 | -3.5 | -3.9 |
| WACC, % | 7.83 | 7.8 | 8.19 | 7.06 | 7.87 | 7.75 | 7.75 | 7.75 | 7.75 | 7.75 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -15.2 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -4 | |||||||||
| Terminal Value | -94 | |||||||||
| Present Terminal Value | -65 | |||||||||
| Enterprise Value | -80 | |||||||||
| Net Debt | 19 | |||||||||
| Equity Value | -99 | |||||||||
| Diluted Shares Outstanding, MM | 16 | |||||||||
| Equity Value Per Share | -6.08 |
What You Will Receive
- Adjustable Forecast Inputs: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Ultralife Corporation’s (ULBI) financial information pre-loaded to facilitate your analysis.
- Automated DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Customizable Financial Inputs: Adjust essential parameters such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
- High Precision Results: Leverages Ultralife Corporation's (ULBI) actual financial data for accurate valuation insights.
- Effortless Scenario Testing: Evaluate various assumptions and analyze results with ease.
- Efficiency Booster: Streamline the valuation process without the hassle of creating intricate models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Ultralife Corporation (ULBI) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Ultralife Corporation’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose the Ultralife Corporation (ULBI) Calculator?
- Accuracy: Utilizes authentic Ultralife financial data for precise calculations.
- Flexibility: Allows users to easily adjust and experiment with input values.
- Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without advanced financial modeling skills.
Who Should Use This Product?
- Finance Students: Master valuation techniques and apply them to real-world data for Ultralife Corporation (ULBI).
- Academics: Integrate industry-standard models into your coursework or research focused on Ultralife Corporation (ULBI).
- Investors: Validate your investment assumptions and analyze valuation results for Ultralife Corporation (ULBI).
- Analysts: Enhance your efficiency with a customizable DCF model tailored for Ultralife Corporation (ULBI).
- Small Business Owners: Understand the analytical methods used for large public companies like Ultralife Corporation (ULBI).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Ultralife Corporation (ULBI) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Ultralife Corporation (ULBI).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.